The medical expenses (including expenses for treating basic diseases, complications and infections in other diseases) of the insured patients in medical institutions, such as drugs and medical services, which are suspected and diagnosed as COVID-19, are all included in the payment scope of the medical insurance fund, and the medical insurance fund shall reimburse them according to the reimbursement ratio of 95%. The rest of the personal burden, such as serious illness insurance and medical assistance, will be paid by the financial department after being paid according to the regulations.